| J9271 | Injection, pembrolizumab, 1 mg | 2,180 | $13,810 | $30.2M |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 1,070 | $24,740 | $26.5M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 114,880 | $210 | $24.6M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 117,670 | $200 | $23.3M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,340 | $7,760 | $18.1M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 125,220 | $140 | $17.4M |
| 90834 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 62,860 | $170 | $10.9M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 73,910 | $130 | $9.9M |
| 90832 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 61,620 | $140 | $8.6M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 42,590 | $200 | $8.3M |